Himadri Interested in Ruetgers

Indian group Himadri Chemicals is interested in bigger European peer Ruetgers Group, which is being put up for sale by private equity owner Triton.

"Once the (sales) process starts, we will definitely look at the company," chief executive Anurag Choudhary told Reuters.

Triton, which acquired Ruetgers in 2008, is looking to divest its holding in the chemicals maker, which primarily makes industrial products derived from distillation of coal tar.

It has hired Goldman Sachs to look for possible buyers and will soon ask for first bids, sources close to the process said.

A price tag of € 700-750 million ($ 925-990 million) could be within reach, an industry source said.

Himadri previously expressed an interest in Ruetgers when former owner Degussa -- now a part of Evonik -- sold the unit in 2008.

Private equity groups are also likely to bid, industry sources said. Private equity groups Bain Capital holds almost 27 % in Himadri and Citigroup Venture Capital International is also a key shareholder.

 

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.